Population Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 Study
dc.contributor.author | Li, Claire H. | |
dc.contributor.author | Pollock, Bruce G. | |
dc.contributor.author | Lyketsos, Constantine G. | |
dc.contributor.author | Vaidya, Vijay | |
dc.contributor.author | Drye, Lea T. | |
dc.contributor.author | Kirshner, Margaret | |
dc.contributor.author | Sorisio, Denise | |
dc.contributor.author | Bies, Robert R. | |
dc.contributor.author | DIADS-2 Research Group | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-05-22T09:52:12Z | |
dc.date.available | 2025-05-22T09:52:12Z | |
dc.date.issued | 2013 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Li CH, Pollock BG, Lyketsos CG, et al. Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study. J Clin Pharmacol. 2013;53(2):234-239. doi:10.1177/0091270012445793 | |
dc.identifier.uri | https://hdl.handle.net/1805/48310 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1177/0091270012445793 | |
dc.relation.journal | Journal of Clinical Pharmacology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Alzheimer disease | |
dc.subject | Antidepressive agents | |
dc.subject | Depression | |
dc.subject | Sertraline | |
dc.title | Population Pharmacokinetic Modeling of Sertraline Treatment in Alzheimer’s Disease Patients: The DIADS-2 Study | |
dc.type | Article |